MorphoSys saw the highest growth of 0.99% in patent filings in May and 1.99% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.49% and grants by 0.26%. GlobalData’s DataBook provides a comprehensive analysis of MorphoSys‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
MorphoSys has been focused on protecting inventions in United States(US) with nine publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 38% filings and 20% grants. The United States(US), Chile(CL), China(CN), and European Patent Office(EPO) patent Office are among the top ten patent offices where MorphoSys is filings its patents. Among the top granted patent authorities, MorphoSys has 33% of its grants in Israel(IL), 20% in United States(US) and 13% in China(CN).
Roche and Johnson & Johnson could be the strongest competitors for MorphoSys
Patents related to rare diseases and cell & gene therapy lead MorphoSys's portfolio
MorphoSys has the highest number of patents in rare diseases followed by, cell & gene therapy and nanomedicine. For rare diseases, nearly 60% of patents were filed and 100% of patents were granted in Q2 2024.
Chronic lymphocytic leukemia (cll) related patents lead MorphoSys portfolio followed by lymphoma, and hodgkin lymphoma (b-cell hodgkin lymphoma)
MorphoSys has highest number of patents in chronic lymphocytic leukemia (cll) followed by lymphoma, hodgkin lymphoma (b-cell hodgkin lymphoma), acute lymphocytic leukemia (all, acute lymphoblastic leukemia), and melanoma. For chronic lymphocytic leukemia (cll), nearly 3% of patents were filed and 13% of patents were granted in Q2 2024.
For comprehensive analysis of MorphoSys's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
